2 authorised products containing Ocrelizumab, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Ocrevus 300 mg concentrate for solution for infusion EU/1/17/1231/001-002 |
Ocrelizumab | Roche Registration GmbH | — |
| Ocrevus 920 mg solution for injection EU/1/17/1231/003 |
Ocrelizumab | Roche Registration GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.